{"id":2935,"date":"2024-04-08T15:15:24","date_gmt":"2024-04-08T13:15:24","guid":{"rendered":"https:\/\/www.institut-myologie.org\/imotion\/?p=2935"},"modified":"2024-04-08T15:17:21","modified_gmt":"2024-04-08T13:17:21","slug":"atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg","status":"publish","type":"post","link":"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/","title":{"rendered":"Atamyo Therapeutics obtient les autorisations pour lancer un essai clinique de th\u00e9rapie g\u00e9nique dans la myopathie des ceintures li\u00e9e \u00e0 SGCG"},"content":{"rendered":"\n<p>Apr\u00e8s d\u00e9j\u00e0 plusieurs preuves de concept, <em>Atamyo Therapeutics<\/em>, une spin-off du laboratoire G\u00e9n\u00e9thon, va d\u00e9marrer un nouvel essai de th\u00e9rapie g\u00e9nique chez des patients atteints de <a href=\"https:\/\/www.afm-telethon.fr\/fr\/fiches-maladies\/myopathie-des-ceintures-de-type-r3-r4-r5-et-r6-sarcoglycanopathie\" target=\"_blank\" rel=\"noreferrer noopener\">myopathie des ceintures (LGMD) R5 li\u00e9e \u00e0 <em>SGCG<\/em> (gamma-sarcoglycanopathie)<\/a>. Il a pour but de tester l\u2019innocuit\u00e9, la pharmacodynamique et l\u2019efficacit\u00e9 de l\u2019ATA-200, un produit issu des travaux d\u2019Isabelle Richard, chercheuse \u00e0 G\u00e9n\u00e9thon. Approuv\u00e9 pour se d\u00e9rouler en France (<strong>\u00e0 I-Motion<\/strong>) et en Italie, ce nouvel essai multicentrique de phase I\/II&nbsp;inclura :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>six enfants \u00e2g\u00e9s de 6 \u00e0 12 ans, marchants et avec un diagnostic de LGMD R5 cliniquement et g\u00e9n\u00e9tiquement confirm\u00e9 ;<\/li>\n\n\n\n<li>deux cohortes recevant chacune une injection unique d\u2019ATA-200 en intraveineux, la premi\u00e8re \u00e0 1 x 10<sup>14<\/sup> vg\/Kg et&nbsp;la deuxi\u00e8me \u00e0 une dose trois plus \u00e9lev\u00e9e&nbsp;;<\/li>\n\n\n\n<li>une \u00e9valuation des effets du produit \u00e0 six mois ;<\/li>\n\n\n\n<li>un suivi des patients sur quatre ans et demi apr\u00e8s la phase d\u2019\u00e9valuation.<\/li>\n<\/ul>\n\n\n\n<p>Le recrutement devrait commencer en mai de cette ann\u00e9e et les premi\u00e8res injections au cours du troisi\u00e8me trimestre&nbsp;2024.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>_____<\/p>\n\n\n\n<p><a href=\"https:\/\/atamyo.com\/press-releases\/press-releases-2024\/atamyo-therapeutics-obtient-les-autorisations-reglementaires-en-europe-pour-lancer-lessai-clinique-de-ata-200-sa-therapie-genique-pour-traiter-la-myopathie-des-ceintures-lgmd-2c-r5\/\" target=\"_blank\" rel=\"noreferrer noopener\"><em>Atamyo Therapeutics obtient les autorisations r\u00e9glementaires en Europe pour lancer l\u2019essai clinique de ATA-200, sa th\u00e9rapie g\u00e9nique pour traiter la myopathie des ceintures\u00a0LGMD-2C\/R5.<\/em><\/a> Atamyo Therapeutics. Communiqu\u00e9 de presse du 26 mars 2024.<\/p>\n\n\n\n<p>Sur le site Clinicaltrials.gov&nbsp;: <a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05973630\" target=\"_blank\" rel=\"noreferrer noopener\">NCT05973630<\/a>.<\/p>\n\n\n\n<p>Voir aussi \u00ab&nbsp;<a href=\"https:\/\/www.afm-telethon.fr\/fr\/actualites\/lgmd-r5-lancement-dun-essai-de-therapie-genique-chez-lhomme\" target=\"_blank\" rel=\"noreferrer noopener\">LGMD&nbsp;R5&nbsp;: lancement d\u2019un essai de th\u00e9rapie g\u00e9nique\u2009chez l\u2019homme\u2009!<\/a>&nbsp;\u00bb.<\/p>\n<\/blockquote>\n","protected":false},"excerpt":{"rendered":"<p>Apr\u00e8s d\u00e9j\u00e0 plusieurs preuves de concept, Atamyo Therapeutics, une spin-off du laboratoire G\u00e9n\u00e9thon, va d\u00e9marrer un nouvel essai de th\u00e9rapie g\u00e9nique chez des patients atteints de myopathie des ceintures (LGMD) R5 li\u00e9e \u00e0 SGCG (gamma-sarcoglycanopathie). Il a pour but de tester l\u2019innocuit\u00e9, la pharmacodynamique et l\u2019efficacit\u00e9 de l\u2019ATA-200, un produit issu des travaux d\u2019Isabelle Richard, &hellip; <a href=\"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/\">Continued<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2935","post","type-post","status-publish","format-standard","hentry","category-non-classifiee"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Atamyo Therapeutics obtient les autorisations pour lancer un essai clinique de th\u00e9rapie g\u00e9nique dans la myopathie des ceintures li\u00e9e \u00e0 SGCG - I-Motion<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atamyo Therapeutics obtient les autorisations pour lancer un essai clinique de th\u00e9rapie g\u00e9nique dans la myopathie des ceintures li\u00e9e \u00e0 SGCG - I-Motion\" \/>\n<meta property=\"og:description\" content=\"Apr\u00e8s d\u00e9j\u00e0 plusieurs preuves de concept, Atamyo Therapeutics, une spin-off du laboratoire G\u00e9n\u00e9thon, va d\u00e9marrer un nouvel essai de th\u00e9rapie g\u00e9nique chez des patients atteints de myopathie des ceintures (LGMD) R5 li\u00e9e \u00e0 SGCG (gamma-sarcoglycanopathie). Il a pour but de tester l\u2019innocuit\u00e9, la pharmacodynamique et l\u2019efficacit\u00e9 de l\u2019ATA-200, un produit issu des travaux d\u2019Isabelle Richard, &hellip; Continued\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/\" \/>\n<meta property=\"og:site_name\" content=\"I-Motion\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-08T13:15:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-08T13:17:21+00:00\" \/>\n<meta name=\"author\" content=\"Anne Berthomier\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anne Berthomier\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/\"},\"author\":{\"name\":\"Anne Berthomier\",\"@id\":\"https:\/\/www.institut-myologie.org\/imotion\/#\/schema\/person\/ecf0b87715a026a200491fe2d7649def\"},\"headline\":\"Atamyo Therapeutics obtient les autorisations pour lancer un essai clinique de th\u00e9rapie g\u00e9nique dans la myopathie des ceintures li\u00e9e \u00e0 SGCG\",\"datePublished\":\"2024-04-08T13:15:24+00:00\",\"dateModified\":\"2024-04-08T13:17:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/\"},\"wordCount\":272,\"publisher\":{\"@id\":\"https:\/\/www.institut-myologie.org\/imotion\/#organization\"},\"articleSection\":[\"Non classifi\u00e9(e)\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/\",\"url\":\"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/\",\"name\":\"Atamyo Therapeutics obtient les autorisations pour lancer un essai clinique de th\u00e9rapie g\u00e9nique dans la myopathie des ceintures li\u00e9e \u00e0 SGCG - I-Motion\",\"isPartOf\":{\"@id\":\"https:\/\/www.institut-myologie.org\/imotion\/#website\"},\"datePublished\":\"2024-04-08T13:15:24+00:00\",\"dateModified\":\"2024-04-08T13:17:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.institut-myologie.org\/imotion\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Atamyo Therapeutics obtient les autorisations pour lancer un essai clinique de th\u00e9rapie g\u00e9nique dans la myopathie des ceintures li\u00e9e \u00e0 SGCG\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.institut-myologie.org\/imotion\/#website\",\"url\":\"https:\/\/www.institut-myologie.org\/imotion\/\",\"name\":\"I-Motion\",\"description\":\"Plateforme d&#039;essais cliniques p\u00e9diatriques pour les maladies neuromusculaires\",\"publisher\":{\"@id\":\"https:\/\/www.institut-myologie.org\/imotion\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.institut-myologie.org\/imotion\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.institut-myologie.org\/imotion\/#organization\",\"name\":\"Institut I-Motion\",\"url\":\"https:\/\/www.institut-myologie.org\/imotion\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.institut-myologie.org\/imotion\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.institut-myologie.org\/imotion\/wp-content\/uploads\/2016\/08\/logoImotion.png\",\"contentUrl\":\"https:\/\/www.institut-myologie.org\/imotion\/wp-content\/uploads\/2016\/08\/logoImotion.png\",\"width\":150,\"height\":51,\"caption\":\"Institut I-Motion\"},\"image\":{\"@id\":\"https:\/\/www.institut-myologie.org\/imotion\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.institut-myologie.org\/imotion\/#\/schema\/person\/ecf0b87715a026a200491fe2d7649def\",\"name\":\"Anne Berthomier\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.institut-myologie.org\/imotion\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/86282695a210f7767b59efc8eb542fb81270ad9c1a9d8bb3bccd9ab2f96782e6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/86282695a210f7767b59efc8eb542fb81270ad9c1a9d8bb3bccd9ab2f96782e6?s=96&d=mm&r=g\",\"caption\":\"Anne Berthomier\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Atamyo Therapeutics obtient les autorisations pour lancer un essai clinique de th\u00e9rapie g\u00e9nique dans la myopathie des ceintures li\u00e9e \u00e0 SGCG - I-Motion","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/","og_locale":"fr_FR","og_type":"article","og_title":"Atamyo Therapeutics obtient les autorisations pour lancer un essai clinique de th\u00e9rapie g\u00e9nique dans la myopathie des ceintures li\u00e9e \u00e0 SGCG - I-Motion","og_description":"Apr\u00e8s d\u00e9j\u00e0 plusieurs preuves de concept, Atamyo Therapeutics, une spin-off du laboratoire G\u00e9n\u00e9thon, va d\u00e9marrer un nouvel essai de th\u00e9rapie g\u00e9nique chez des patients atteints de myopathie des ceintures (LGMD) R5 li\u00e9e \u00e0 SGCG (gamma-sarcoglycanopathie). Il a pour but de tester l\u2019innocuit\u00e9, la pharmacodynamique et l\u2019efficacit\u00e9 de l\u2019ATA-200, un produit issu des travaux d\u2019Isabelle Richard, &hellip; Continued","og_url":"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/","og_site_name":"I-Motion","article_published_time":"2024-04-08T13:15:24+00:00","article_modified_time":"2024-04-08T13:17:21+00:00","author":"Anne Berthomier","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Anne Berthomier","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/#article","isPartOf":{"@id":"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/"},"author":{"name":"Anne Berthomier","@id":"https:\/\/www.institut-myologie.org\/imotion\/#\/schema\/person\/ecf0b87715a026a200491fe2d7649def"},"headline":"Atamyo Therapeutics obtient les autorisations pour lancer un essai clinique de th\u00e9rapie g\u00e9nique dans la myopathie des ceintures li\u00e9e \u00e0 SGCG","datePublished":"2024-04-08T13:15:24+00:00","dateModified":"2024-04-08T13:17:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/"},"wordCount":272,"publisher":{"@id":"https:\/\/www.institut-myologie.org\/imotion\/#organization"},"articleSection":["Non classifi\u00e9(e)"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/","url":"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/","name":"Atamyo Therapeutics obtient les autorisations pour lancer un essai clinique de th\u00e9rapie g\u00e9nique dans la myopathie des ceintures li\u00e9e \u00e0 SGCG - I-Motion","isPartOf":{"@id":"https:\/\/www.institut-myologie.org\/imotion\/#website"},"datePublished":"2024-04-08T13:15:24+00:00","dateModified":"2024-04-08T13:17:21+00:00","breadcrumb":{"@id":"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.institut-myologie.org\/imotion\/2024\/04\/08\/atamyo-therapeutics-obtient-les-autorisations-pour-lancer-un-essai-clinique-de-therapie-genique-dans-la-myopathie-des-ceintures-liee-a-sgcg\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.institut-myologie.org\/imotion\/"},{"@type":"ListItem","position":2,"name":"Atamyo Therapeutics obtient les autorisations pour lancer un essai clinique de th\u00e9rapie g\u00e9nique dans la myopathie des ceintures li\u00e9e \u00e0 SGCG"}]},{"@type":"WebSite","@id":"https:\/\/www.institut-myologie.org\/imotion\/#website","url":"https:\/\/www.institut-myologie.org\/imotion\/","name":"I-Motion","description":"Plateforme d&#039;essais cliniques p\u00e9diatriques pour les maladies neuromusculaires","publisher":{"@id":"https:\/\/www.institut-myologie.org\/imotion\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.institut-myologie.org\/imotion\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.institut-myologie.org\/imotion\/#organization","name":"Institut I-Motion","url":"https:\/\/www.institut-myologie.org\/imotion\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.institut-myologie.org\/imotion\/#\/schema\/logo\/image\/","url":"https:\/\/www.institut-myologie.org\/imotion\/wp-content\/uploads\/2016\/08\/logoImotion.png","contentUrl":"https:\/\/www.institut-myologie.org\/imotion\/wp-content\/uploads\/2016\/08\/logoImotion.png","width":150,"height":51,"caption":"Institut I-Motion"},"image":{"@id":"https:\/\/www.institut-myologie.org\/imotion\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.institut-myologie.org\/imotion\/#\/schema\/person\/ecf0b87715a026a200491fe2d7649def","name":"Anne Berthomier","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.institut-myologie.org\/imotion\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/86282695a210f7767b59efc8eb542fb81270ad9c1a9d8bb3bccd9ab2f96782e6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/86282695a210f7767b59efc8eb542fb81270ad9c1a9d8bb3bccd9ab2f96782e6?s=96&d=mm&r=g","caption":"Anne Berthomier"}}]}},"_links":{"self":[{"href":"https:\/\/www.institut-myologie.org\/imotion\/wp-json\/wp\/v2\/posts\/2935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.institut-myologie.org\/imotion\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.institut-myologie.org\/imotion\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.institut-myologie.org\/imotion\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.institut-myologie.org\/imotion\/wp-json\/wp\/v2\/comments?post=2935"}],"version-history":[{"count":3,"href":"https:\/\/www.institut-myologie.org\/imotion\/wp-json\/wp\/v2\/posts\/2935\/revisions"}],"predecessor-version":[{"id":2938,"href":"https:\/\/www.institut-myologie.org\/imotion\/wp-json\/wp\/v2\/posts\/2935\/revisions\/2938"}],"wp:attachment":[{"href":"https:\/\/www.institut-myologie.org\/imotion\/wp-json\/wp\/v2\/media?parent=2935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.institut-myologie.org\/imotion\/wp-json\/wp\/v2\/categories?post=2935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.institut-myologie.org\/imotion\/wp-json\/wp\/v2\/tags?post=2935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}